Reduced antiplatelet effect of aspirin at the end of the dosing interval in CAD patients with type 2 diabetes mellitus.

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date5 Oct 2013
Publication statusAccepted/In press - 5 Oct 2013

Cite this